Expanding Steroid Sulfatase Inhibition: Novel Applications and Use Cases

This inventive concept explores the application of steroid sulfatase inhibitors in novel fields, including athletic performance, cognitive function, skin aging, neurodegenerative disease prediction, and fertility enhancement, leveraging the core technology of the original patent to address unmet needs in these areas.

The original patent focused on the prevention and treatment of obesity and lipid-related metabolic disorders. However, the limitations of this approach became apparent as the potential of steroid sulfatase inhibitors remained largely untapped in other fields. This inventive concept addresses the problem of unexplored applications by expanding the scope of steroid sulfatase inhibition to tackle diverse challenges in human health and performance.

The new claims encompass five distinct applications of steroid sulfatase inhibitors: athletic performance enhancement, cognitive function improvement in ADHD individuals, promoting healthy skin aging, predicting and preventing neurodegenerative diseases, and enhancing fertility in PCOS individuals. Each application involves the administration of a pharmaceutically effective amount of a steroid sulfatase inhibitor, often in combination with other agents or tools. The inhibitors are designed to interact with specific biological pathways, leading to improved outcomes in their respective fields.

The new claims introduce a significant departure from the original patent's focus on obesity and lipid-related metabolic disorders. The inventive step lies in the recognition of steroid sulfatase inhibitors' potential in novel fields, combined with the development of tailored formulations and administration methods to address specific challenges in each area.

Alternative embodiments of this inventive concept could include the development of transdermal patches, oral formulations, or injectable solutions for the administration of steroid sulfatase inhibitors. Variations might involve the use of different inhibitor compounds, combination therapies, or personalized dosing regimens to optimize outcomes in each application area.

The commercial potential of this inventive concept is substantial, with applications in the athletic performance, cognitive function, skin care, neurodegenerative disease, and fertility markets. The target industries include pharmaceutical, biotechnology, and healthcare companies, as well as sports medicine and wellness organizations.